U.S. Markets open in 3 hrs 56 mins

What Analysts Expect for Abiomed

Mike Benson
What Analysts Expect for Abiomed

How Do Abiomed’s Valuations Look in September? Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018. The earnings per share are expected to be $4.66 in 2019.